Table 1.
Demographic, clinical, laboratory findings of patients on admission
| Characteristics | Total(n = 114) | Low risk of Sarcopenia (n = 76) | High risk of sarcopenia (n = 38) | p value |
|---|---|---|---|---|
| Age, Years | 69.52 ± 7.25 | 68.93 ± 7.00 | 72.05 ± 8.36 | 0.038 |
| Sex | ||||
| Female | 57(50.00%) | 38(50.00%) | 19(50.00%) | 1.000 |
| Male | 57(50.00%) | 38(50.00%) | 19(50.00%) | |
| Body Mass Index | 23.46 ± 3.18 | 23.57 ± 3.23 | 23.20 ± 3.08 | 0.576 |
| Smoking | 19(16.67%) | 12(15.79%) | 7(18.42%) | 0.722 |
| Comorbidity | ||||
| Hypertension | 57(50.00%) | 37(48.68%) | 20(52.63%) | 0.691 |
| Diabetes | 20(17.54%) | 14(18.42%) | 6(15.79%) | 0.728 |
| Coronary heart disease | 10(8.77%) | 4(5.26%) | 6(15.79%) | 0.061 |
| Stroke | 6(5.26%) | 2(2.63%) | 4(10.53%) | 0.075 |
| Cancer | 9(7.89%) | 7(9.21%) | 2(5.26%) | 0.461 |
| Chronic pulmonary disease | 14(12.28%) | 8(10.52%) | 6(15.79%) | 0.420 |
| Chronic kidney disease | 7(6.14%) | 4(5.26%) | 3(7.89%) | 0.581 |
| Symptoms | ||||
| Fever | 87(76.32%) | 60(78.95%) | 27(71.05%) | 0.350 |
| Fatigue | 66(52.63%) | 38(50.00%) | 28(73.68%) | 0.019 |
| Myalgia | 10(8.77%) | 6(7.89%) | 4(10.53%) | 0.640 |
| Pharyngalgia | 4(3.51%) | 3(3.95%) | 1(2.63%) | 0.710 |
| Dry cough | 72(63.16%) | 47(61.84%) | 25(65.79%) | 0.680 |
| Expectoration | 37(32.46%) | 24(31.58%) | 13(34.21%) | 0.777 |
| Hemoptysis | 5(4.39%) | 4(5.26%) | 1(2.63%) | 0.518 |
| Dyspnea | 46(40.35%) | 24(31.58%) | 22(57.89%) | 0.007 |
| Chest pain | 4(3.51%) | 2(2.63%) | 2(5.26%) | 0.472 |
| Anorexia | 69(60.53%) | 41(53.95%) | 28(73.68%) | 0.042 |
| Diarrhea | 12(10.53%) | 9(11.84%) | 3(7.89%) | 0.517 |
| Nausea | 11(9.65%) | 6(7.89%) | 5(13.16%) | 0.370 |
| Laboratory findings | ||||
| White blood cell count (× 109/L) | 6.50(5.28–8.52) | 6.48(5.34–8.51) | 6.85(4.89–9.72) | 0.016 |
| Neutrophil count (×109/L) | 4.19(3.01–5.91) | 4.78(3.40–5.95) | 5.14(3.46–8.59) | 0.002 |
| Lymphocyte count (×109/L) | 0.82(0.58–1.13) | 0.90(0.66–1.35) | 0.69(0.52–1.12) | 0.002 |
| Platelet (×109/L) | 204.00(161.00–265.00) | 199.00(171.00–261.00) | 215.50(152.00–270.50) | 0.766 |
| Hemoglobin, g/L | 120.00 ± 20.91 | 116.87 ± 21.06 | 126.50 ± 18.46 | 0.018 |
| Albumin, g/L | 34.90(32.10–37.45) | 34.10(32.20–36.50) | 36.85(32.30–38.25) | 0.147 |
| Creatinine, μmol/L | 65.00(53.00–79.00) | 61.00(53.00–82.00) | 65.00(49.00–73.00) | 0.274 |
| D-Dimer, mg/L | 1.55(0.69–4.65) | 1.07(0.56–2.47) | 2.23(1.17–7.80) | 0.013 |
| C-reactive protein, mg/L | 59.10(21.30–110.20) | 61.30(21.30–110.70) | 53.05(21.75–99.00) | 0.651 |
| Procalcitonin, ng/mL | 0.09(0.06–0.21) | 0.07(0.05–0.22) | 0.10(0.06–0.18) | 0.003 |
| BNP, pg/mL | 270.50(135.00–661.00) | 266.80(122.70–457.50) | 348.40(159.50–813.70) | 0.027 |
| CD + 3, count/μl | 518.00(317.00–804.00) | 538.00(345.00–850.00) | 432.00(235.00–707.00) | 0.007 |
| CD + 4, count/μl | 348.00(212.00–513.00) | 378.00(230.00–559.00) | 277.00(150.50–476.50) | 0.006 |
| CD + 8, count/μl | 167.00(81.00–279.00) | 193.00(94.00–258.00) | 122.50(76.00–285.00) | 0.013 |
Data are median (IQR), n (%). p values were calculated by Mann-Whitney U test, χ2 test, or Fisher’s exact test, as appropriate
Abbreviations: BNP Brain Natriuretic Peptide